Your session is about to expire
← Back to Search
Dysphagia Therapy for Alzheimer's Disease
Study Summary
This trial is testing whether a new dysphagia therapy can help reduce the risk of pneumonia in patients with Alzheimer's Disease and related dementias.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My dementia is mainly caused by issues with my brain's blood vessels.I am between 50 and 99 years old.My caregiver cannot legally agree to decisions for me.I have been diagnosed with dementia or significant memory loss.I have had head or neck cancer or a condition that affects my ability to swallow.
- Group 1: Lingual Strengthening Intervention
- Group 2: Saliva Substitute and Lingual Strengthening Intervention
- Group 3: Usual care
- Group 4: Saliva Substitute Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Do seniors qualify for inclusion in this clinical experiment?
"This investigation is aimed at those aged 50 to 99. There are 41 studies on the topic for minors, while 818 trials are available for senior citizens."
How many participants is the research team recruiting for this trial?
"Yes, the data accessible through clinicaltrials.gov demonstrates that this medical experiment is presently accepting qualified applicants. It was initially announced on September 25th 2020 and edited most recently on June 9th 2022 with an aim to recruit 152 participants from one site."
Are there any opportunities to participate in this experiment presently?
"This clinical trial is currently recruiting for participants. As per the information found on clinicaltrials.gov, it was initially posted in September 2020 and most recently updated June 2022."
What criteria must be met to qualify for enrollment in this medical research program?
"This medical trial aims to enrol 152 individuals suffering from Alzheimer's disease who are between the age of 50 and 99. To be eligible, each patient must possess a Clinical Dementia Rating (CDR) scale score ranging from 0.5 to 2.0; in addition, they must speak English fluently and have an actively involved caregiver aged 18 or older with contact at least once per week as well as access to a functioning telephone line."
Share this study with friends
Copy Link
Messenger